Orchard Therapeutics PLC Sponsored ADR Debt to Equity Ratio 2019-2023 | ORTX
Current and historical debt to equity ratio values for Orchard Therapeutics PLC Sponsored ADR (ORTX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Orchard Therapeutics PLC Sponsored ADR debt/equity for the three months ending September 30, 2023 was .
Debt/Equity Ratio Historical Data |
Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
2023-09-30 |
$0.12B |
$0.08B |
1.52 |
2023-06-30 |
$0.12B |
$0.11B |
1.13 |
2023-03-31 |
$0.12B |
$0.10B |
1.14 |
2022-12-31 |
$0.12B |
$0.10B |
1.23 |
2022-09-30 |
$0.11B |
$0.12B |
0.89 |
2022-06-30 |
$0.11B |
$0.15B |
0.77 |
2022-03-31 |
$0.12B |
$0.18B |
0.66 |
2021-12-31 |
$0.11B |
$0.21B |
0.54 |
2021-09-30 |
$0.11B |
$0.24B |
0.47 |
2021-06-30 |
$0.10B |
$0.26B |
0.38 |
2021-03-31 |
$0.09B |
$0.30B |
0.32 |
2020-12-31 |
$0.10B |
$0.18B |
0.57 |
2020-09-30 |
$0.09B |
$0.21B |
0.44 |
2020-06-30 |
$0.09B |
$0.23B |
0.39 |
2020-03-31 |
$0.09B |
$0.27B |
0.34 |
2019-12-31 |
$0.10B |
$0.30B |
0.34 |
2019-09-30 |
$0.08B |
$0.34B |
0.22 |
2019-06-30 |
$0.09B |
$0.37B |
0.23 |
2019-03-31 |
$0.04B |
$0.29B |
0.15 |
2018-12-31 |
$0.06B |
$0.31B |
0.18 |
2018-09-30 |
$0.00B |
|
0.00 |
2018-06-30 |
$0.00B |
|
0.00 |
2018-03-31 |
$0.00B |
|
0.00 |